NXGL.NASDAQNexgel, INC

Form 4: NEXGEL Director Scott Robert Henry Acquires Stock Options

Sentiment:

SEC Form 4 Filing


Director Scott Robert Henry acquired stock options for 25,000 shares of NEXGEL, INC. common stock on September 13, 2024.

Summary

  • On September 13, 2024, Scott Robert Henry, a director of NEXGEL, INC., was granted stock options to purchase 25,000 shares of common stock.
  • The exercise price of the stock options is $2.72 per share.
  • The options vest in installments, with 6,250 shares vesting on September 30, 2024, and the remaining 18,750 shares vesting monthly over the following nine months.
  • The stock options expire on September 13, 2034.
  • The grant was made pursuant to the Issuer's 2019 Long-Term Incentive Plan, as amended, for services as a member of the Issuer's Board of Directors.
  • In the event of a Change in Control (as defined in the Plan), any unvested shares underlying the stock option shall accelerate in accordance with the terms of the Plan.

Sentiment

Score: 7

Explanation: The document indicates a standard compensation practice, suggesting confidence in the company's future. The vesting schedule and exercise price are typical, indicating a balanced approach to incentivizing the director.

Positives

  • The granting of stock options to a director aligns their interests with those of the shareholders.
  • The vesting schedule incentivizes continued service on the board.

Industry Context

Stock option grants are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with shareholders and incentivizing long-term value creation.

Comparison to Industry Standards

  • Stock option grants are a standard component of executive compensation packages in the biotechnology and medical device industries.
  • The vesting schedule and exercise price are typical for such grants, designed to incentivize long-term performance.
  • Comparable companies often use similar equity-based compensation plans to attract and retain talent.

Stakeholder Impact

  • The stock option grant could positively impact shareholders by aligning the director's interests with the company's long-term success.
  • The director is incentivized to contribute to the company's growth and profitability.

Key Dates

DateDescription
09/13/2024Date of the stock option grant and earliest transaction date
09/30/2024Date when 6,250 shares of the stock option vest
10/31/2024Start date for monthly vesting of the remaining 18,750 shares
06/30/2025Date when the final 2,078 shares vest
09/13/2034Expiration date of the stock options
09/17/2024Date of signature on the Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.